SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-281337
Filing Date
2022-11-09
Accepted
2022-11-09 17:09:03
Documents
12
Period of Report
2022-11-08
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K d421011d8k.htm   iXBRL 8-K 28872
  Complete submission text file 0001193125-22-281337.txt   155064

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aclx-20221108.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20221108_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20221108_pre.xml EX-101.PRE 11701
6 EXTRACTED XBRL INSTANCE DOCUMENT d421011d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 221373638
SIC: 2836 Biological Products, (No Diagnostic Substances)